Suppr超能文献

解析神秘蛋白酶

Deciphering cryptic proteases.

作者信息

Liz M A, Sousa M M

机构信息

Molecular Neurobiology Group, Instituto de Biologia Molecular e Celular, Rua Campo Alegre 823, 4150-180, Porto, Portugal.

出版信息

Cell Mol Life Sci. 2005 May;62(9):989-1002. doi: 10.1007/s00018-005-4544-2.

Abstract

Proteases are deeply involved in physiology and pathology. For most, the mechanism is well defined but several fail to display typical protease features (as is the case of the four proteases contained in fibronectin, the inhibitor-resistant mesotrypsin and the proteosomal deubiquitinating enzyme) or have unclear physiological function (such as calpain-like proteins, transthyretin and factor seven activating protease). In other cases, such as in peroxisomal processing proteases, although substrates are defined, the enzyme remains undiscovered. Furthermore, several proteases were identified in pathological conditions, namely secretases in Alzheimer's disease and gross cystic disease fluid protein 15 kDa in breast cancer, when most likely their physiological substrate is still hidden. Lastly, the evolutionary conservation of proteolytic enzymes raises questions related to the origin of biological events, such as the origin of cystein proteases and cell death responses. In this review we will discuss the above cryptic enzymes, as they will probably be relevant in the future.

摘要

蛋白酶在生理和病理过程中都有着深入的参与。对于大多数蛋白酶而言,其作用机制已被明确,但仍有一些蛋白酶未能展现出典型的蛋白酶特征(如纤连蛋白中包含的四种蛋白酶、抗抑制剂的中胰蛋白酶以及蛋白酶体去泛素化酶),或者其生理功能尚不明确(如钙蛋白酶样蛋白、转甲状腺素蛋白和因子 VII 激活蛋白酶)。在其他情况下,如过氧化物酶体加工蛋白酶,尽管其底物已被确定,但该酶仍未被发现。此外,一些蛋白酶是在病理条件下被鉴定出来的,即在阿尔茨海默病中的分泌酶以及乳腺癌中的 15 kDa 巨大囊性疾病液蛋白,而此时它们最可能对应的生理底物可能仍不为人知。最后,蛋白水解酶的进化保守性引发了与生物事件起源相关的问题,如半胱氨酸蛋白酶的起源和细胞死亡反应。在本综述中,我们将讨论上述这些神秘的酶,因为它们可能在未来具有重要意义。

相似文献

1
Deciphering cryptic proteases.
Cell Mol Life Sci. 2005 May;62(9):989-1002. doi: 10.1007/s00018-005-4544-2.
2
A cut above the rest: the regulatory function of plant proteases.
Planta. 2004 Dec;220(2):183-97. doi: 10.1007/s00425-004-1407-2. Epub 2004 Oct 29.
3
Proteases universally recognize beta strands in their active sites.
Chem Rev. 2005 Mar;105(3):973-99. doi: 10.1021/cr040669e.
4
Substrate specificity of gamma-secretase and other intramembrane proteases.
Cell Mol Life Sci. 2008 May;65(9):1311-34. doi: 10.1007/s00018-008-7462-2.
5
Intramembrane-cleaving proteases.
J Biol Chem. 2009 May 22;284(21):13969-73. doi: 10.1074/jbc.R800039200. Epub 2009 Feb 3.
6
Opportunities for structure-based design of protease-directed drugs.
Curr Opin Struct Biol. 2006 Dec;16(6):769-75. doi: 10.1016/j.sbi.2006.10.014. Epub 2006 Nov 16.
8
Activity-based probes as a tool for functional proteomic analysis of proteases.
Expert Rev Proteomics. 2008 Oct;5(5):721-30. doi: 10.1586/14789450.5.5.721.
9
The S8 serine, C1A cysteine and A1 aspartic protease families in Arabidopsis.
Phytochemistry. 2004 Jan;65(1):43-58. doi: 10.1016/j.phytochem.2003.09.005.
10
Alzheimer's alpha-secretase may be a calcium-dependent protease.
FEBS Lett. 1997 Nov 10;417(2):163-7. doi: 10.1016/s0014-5793(97)01214-3.

引用本文的文献

1
Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.
Biochim Biophys Acta. 2013 Apr;1832(4):517-26. doi: 10.1016/j.bbadis.2013.01.003. Epub 2013 Jan 9.
2
Fibronectin: functional character and role in alcoholic liver disease.
World J Gastroenterol. 2011 May 28;17(20):2482-99. doi: 10.3748/wjg.v17.i20.2482.
3
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Annu Rev Biochem. 2009;78:363-97. doi: 10.1146/annurev.biochem.78.082307.091526.
5
IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC).
J Cancer Res Clin Oncol. 2008 Oct;134(10):1059-65. doi: 10.1007/s00432-008-0390-6. Epub 2008 Apr 3.
6
Novel peroxisomal protease Tysnd1 processes PTS1- and PTS2-containing enzymes involved in beta-oxidation of fatty acids.
EMBO J. 2007 Feb 7;26(3):835-45. doi: 10.1038/sj.emboj.7601525. Epub 2007 Jan 25.
7
The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid.
Neurochem Res. 2007 Apr-May;32(4-5):609-23. doi: 10.1007/s11064-006-9131-x. Epub 2006 Aug 31.

本文引用的文献

1
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
N Engl J Med. 2016 Jul 14;375(2):111-21. doi: 10.1056/NEJMoa1513614. Epub 2016 May 5.
2
The role of catheter ablation in the management of ventricular tachycardia.
Eur Heart J. 2016 Feb 14;37(7):594-609. doi: 10.1093/eurheartj/ehv421. Epub 2015 Aug 31.
6
Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis.
Eur Heart J. 2013 Feb;34(8):560-71. doi: 10.1093/eurheartj/ehs453. Epub 2012 Dec 21.
7
Catheter ablation of ventricular tachycardia in nonischemic heart disease.
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):992-1000. doi: 10.1161/CIRCEP.112.971341. Epub 2012 Aug 31.
9
Ventricular tachycardia ablation: evolution of patients and procedures over 8 years.
Circ Arrhythm Electrophysiol. 2008 Aug;1(3):153-61. doi: 10.1161/CIRCEP.108.769471. Epub 2008 Jun 6.
10
Prophylactic catheter ablation for the prevention of defibrillator therapy.
N Engl J Med. 2007 Dec 27;357(26):2657-65. doi: 10.1056/NEJMoa065457.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验